[Validation of the FINDRISC (FINnish Diabetes RIsk SCore) for prediction of the risk of type 2 diabetes in a population of southern Spain. Pizarra Study]

Med Clin (Barc). 2012 Apr 14;138(9):371-6. doi: 10.1016/j.medcli.2011.05.025. Epub 2011 Sep 21.
[Article in Spanish]

Abstract

Background and objective: The aim of this study was to validate the ability of the Finnish Diabetes Risk Score (FINDRISC) to predict the risk of DM2 in a population of south-eastern Spain (Pizarra Study).

Subjects and methods: The Pizarra Study is a population-based prospective study developed in the town of Pizarra (Málaga). The first phase of the study was conducted in 1997-1998, including 1051 individuals aged 18-65 years randomly selected from the municipal census of the town. In 2003-2004 the subjects participating in the first study were reassessed. 824 individuals completed the second phase of the study (78.4%). All participants without known diabetes underwent an oral glucose tolerance test both at baseline and follow-up. We evaluated the ability of the FINDRISC to detect undiagnosed DM2 (first phase: cross-sectional study) and in predicting the incidence of DM2 (second phase: cohort study).

Results: The test showed good results both to detect undiagnosed DM2 (ROC-AUC 0.74) and to predict incident DM2 (ROC-AUC 0.75). The best prediction of risk of incident DM2 was found in those subjects with fasting glucose >100mg/dl and a FINDRISC ≥9 (OR: 19.37; 95%IC: 8,86-42,34; P<.0001).

Conclusions: The results of our study show that FINDRISC can be a useful tool to detect subjects at high risk of diabetes in this population.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anthropometry
  • Blood Glucose / analysis
  • Body Mass Index
  • Comorbidity
  • Diabetes Mellitus, Type 2 / epidemiology*
  • Dyslipidemias / epidemiology
  • Fasting / blood
  • Female
  • Follow-Up Studies
  • Glucose Tolerance Test
  • Humans
  • Hypertension / epidemiology
  • Male
  • Middle Aged
  • Models, Biological
  • Obesity / epidemiology
  • Prospective Studies
  • Sampling Studies
  • Severity of Illness Index*
  • Spain / epidemiology
  • Young Adult

Substances

  • Blood Glucose